| Description |
1 online resource |
| Contents |
PRESCRIPTION DRUG MONITORING; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Chapter 1: Prescription Drug Monitoring Programs*; Summary; Introduction; Prescription Drug Monitoring Programs (PDMPs); Program Operation; Interstate Information Sharing and Interoperability; Compliance and Enforcement Mechanisms; Program Costs; PDMP Financing; PDMP Effectiveness; Effectiveness Research; Limitations of the Research; Potential Unintended Consequences; Potential to Increase Effectiveness; Federal Grant Programs for State PDMPs; Harold Rogers PDMP; Grant Purpose Areas |
|
AppropriationsNational All Schedules Prescription Electronic Reporting Act of 2005 (NASPER); Grant Purpose Areas; Appropriations; Program Comparison; Selected Policy Issues; Role of PDMPs in the Federal Prescription Drug Abuse Strategy; Balancing Stakeholder Concerns; Federal Role in Interstate Information Sharing and Interoperability; End Notes; Chapter 2: Statement of John L. Eadie, Director, Prescription Drug Monitoring Program Center of Excellence, Brandeis University. Hearing on ''Prescription Drug Abuse''*; I. The Center; II. Prescription Drug Monitoring Programs -- A brief overview |
|
III. PDMPs are for both Public Health and Public SafetyIV. A New Generation of PDMPs: Adopting Best Practices; IV. A. Proactive, Unsolicited Reports; IV. B. Prescribers and Pharmacists:; Requested (Solicited) Reports; IV. C. Law Enforcement Agencies: Requested (Solicited) Reports; IV. D. Health Professional Licensing Agencies; IV. E. Pharmacies: Verifications Prior to Dispensing; IV. F. Expanding PDMP Data Use to Other Users; IV. G. Interstate PDMP Data Sharing; V. Prescription Behavior Surveillance System; V.A. Early Warning System; VI. Third Party Health Care Payers and PDMPs |
|
VII. Mandatory Prescriber EducationVIII. Issues the Senate Caucus on International Narcotic Control Might Consider; Chapter 3: Prescription Drug Data: HHS Has Issued Health Privacy and Security Regulations but Needs to Improve Guidance and Oversight*; Why GAO Did This Study; What GAO Recommends; What GAO Found; Abbreviations; Background; Prescription Drug Use Information Can Be Used for Purposes Other than Direct Clinical Care |
|
Federal Laws Establish Privacy and Security Protections of Individually Identifiable Health Information Including Prescription Drug Use Information Used for Purposes Other than Direct Clinical CareHHS Has a Framework for Protecting Medicare Beneficiaries' Prescription Drug Use Information but Has Not Issued Required Guidance or Implemented Required Oversight Capabilities; HHS Issued Regulations to Implement Key HIPAA and HITECH Act Requirements for Protecting PHI; HHS Issued the HIPAA Privacy and Security Rules to Meet HIPAA Requirements |
| Summary |
Annotation In the midst of national concern over illicit drug use and abuse, prescription drug abuse has been identified as the United States' fastest growing drug problem. Nearly all prescription drugs involved in overdoses are originally prescribed by a physician. Attention has been directed toward preventing the diversion of prescription drugs after the prescriptions are dispensed. Prescription drug monitoring programs (PDMPs) maintain statewide electronic databases of prescriptions dispensed for controlled substances. This book provides an overview of PDMPs with a focus on supporting access to legitimate medical use of controlled substances |
| Notes |
Print version record |
| Subject |
Drug utilization -- United States
|
|
Medication abuse -- United States
|
|
MEDICAL -- Pharmacology.
|
|
Drug utilization
|
|
Medication abuse
|
|
United States
|
| Form |
Electronic book
|
| Author |
Kaelin, Christopher J
|
|
Nutting, Meredith
|
| ISBN |
9781622579167 |
|
162257916X |
|
